<code id='125D5AFE9E'></code><style id='125D5AFE9E'></style>
    • <acronym id='125D5AFE9E'></acronym>
      <center id='125D5AFE9E'><center id='125D5AFE9E'><tfoot id='125D5AFE9E'></tfoot></center><abbr id='125D5AFE9E'><dir id='125D5AFE9E'><tfoot id='125D5AFE9E'></tfoot><noframes id='125D5AFE9E'>

    • <optgroup id='125D5AFE9E'><strike id='125D5AFE9E'><sup id='125D5AFE9E'></sup></strike><code id='125D5AFE9E'></code></optgroup>
        1. <b id='125D5AFE9E'><label id='125D5AFE9E'><select id='125D5AFE9E'><dt id='125D5AFE9E'><span id='125D5AFE9E'></span></dt></select></label></b><u id='125D5AFE9E'></u>
          <i id='125D5AFE9E'><strike id='125D5AFE9E'><tt id='125D5AFE9E'><pre id='125D5AFE9E'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:fashion    Page View:4248
          Bruce Broussard. -- health business coverage from STAT
          Humana CEO Bruce Broussard Jason DeCrow/AP

          Bruce Broussard, CEO of health insurance giant Humana, will step down next year after leading the company for more than a decade.

          Humana named Jim Rechtin — who is the CEO of Envision Healthcare, the controversial physician staffing firm that is working its way through bankruptcy — as Broussard’s replacement. Rechtin will serve as president and chief operating officer starting Jan. 8 and then take over as CEO in the “latter half of 2024,” the company said in a news release.

          advertisement

          Humana’s stock fell by more than 2% on the news Wednesday morning.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          ChatGPT in medicine: STAT answers readers' burning questions
          ChatGPT in medicine: STAT answers readers' burning questions

          MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

          read more
          Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead
          Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

          HasPhRMAlostitsfangs?Are11th-hourchangesominousforclinicaltrials?Andwhat’snextinpainmedicine?Wecover

          read more
          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more

          The response to Covid

          AdobeInMarch,ateamofChinesescientistsstudyingwhethertheantiviralremdesivirwaseffectiveagainstCovid-1